PREVU cholesterol test trial
This article was originally published in The Tan Sheet
Executive Summary
A clinical trial evaluating the PREVU Point of Care skin sterol test will measure the relationship between skin sterol values and already-established coronary artery disease markers such as ankle/brachial blood pressure index and vascular compliance, International Medical Innovations announces. The study will follow 100 patients at high risk for cardiovascular disease and not taking cholesterol-lowering medication. The product measures cholesterol levels that accumulate in skin tissue. McNeil Consumer & Specialty Pharmaceuticals reached a licensing agreement with IMI in June. The firms are developing PREVU predictive tests for medical, laboratory and home use (1"The Tan Sheet" June 7, 2004, p. 10)...